Search by Drug Name or NDC

    NDC 25021-0674-20 etomidate 2 mg/mL Details

    etomidate 2 mg/mL

    etomidate is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is ETOMIDATE.

    Product Information

    NDC 25021-0674
    Product ID 25021-674_b6654b66-f0c8-49be-b43b-e3295cfd2a55
    Associated GPIs 70400010002020
    GCN Sequence Number 030871
    GCN Sequence Number Description etomidate VIAL 2 MG/ML INTRAVEN
    HIC3 H2C
    HIC3 Description GENERAL ANESTHETICS,INJECTABLE
    GCN 12831
    HICL Sequence Number 001554
    HICL Sequence Number Description ETOMIDATE
    Brand/Generic Generic
    Proprietary Name etomidate
    Proprietary Name Suffix n/a
    Non-Proprietary Name etomidate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 2
    Active Ingredient Units mg/mL
    Substance Name ETOMIDATE
    Labeler Name Sagent Pharmaceuticals
    Pharmaceutical Class General Anesthesia [PE], General Anesthetic [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA215028
    Listing Certified Through n/a

    Package

    NDC 25021-0674-20 (25021067420)

    NDC Package Code 25021-674-20
    Billing NDC 25021067420
    Package 10 VIAL in 1 CARTON (25021-674-20) / 20 mL in 1 VIAL
    Marketing Start Date 2012-08-10
    NDC Exclude Flag N
    Pricing Information N/A